We are investigating the role of membrane-bound peptidases in the inactivation of neuropeptides in Aplysia. We found neuropeptide-degrading enzymes in all tested tissues of Aplysia. This activity was very sensitive to amastatin, suggesting that the major enzyme was an aminopeptidase. Accordingly, this enzyme hydrolysed [3H]leuenkephalin at the tyr1-gly2 bond and FMRFamide at the Phc1-Met2 bond as determined by HPLC analysis of cleavage products. Enzymatic studies in the absence or presence of aminopeptidase inhibitors revealed that this enzyme is a metallopeptidase with the same enzymatic characteristics as the mammalian aminopeptidase N. However, the enzyme from Aplysia was able to hydrolyse substrates known to be resistant to mammalian aminopeptidases due to the presence of a D-amino acid. Inhibition of this aminopeptidase with amastatin allowed us to characterize a second enkephalin-degrading enzyme in the kidney plasma membranes. This enzyme cleaved leu-enkephalin at the Gly3-Phe4 bond and its activity is sensitive to neutral endopeptidase inhibitors. After separation of kidney membrane proteins by SDS-PAGE, a specific radioiodinated inhibitor ([125I]RB104) which binds the Aplysia endopeptidase with high affinity recognized a protein band with an apparent molecular mass of 140 kDa. The labelling was abolished by specific NEP inhibitors.
INTRODUCTION

Degradation
of secreted neuropeptides appears to be mediated by a broad range of relatively non specific peptidases (KENNY et al., 1987 (MALFROY et al., 1978; ROQUES et al., 1980; PATEY et al., 1981; DE LA BAUME et al., 1983) . Other roles have been proposed in hypertension, congestive heart failure and in bronchoconstriction (for reviews see RoQUES & BEAUMONT, 1990; WILKINS Bt al., 1993; LILLY et al., 1993) .
The understanding of the physiological role of neuropeptide-degrading enzymes could benefit from studies on a simple, well integrated peptidergic system. Using well studied peptide substrates, we have investigated the presence of peptidases in kidney, ovotestis, head ganglia, heart and hemolymph of the mollusc A. californica. In this paper, we report the presence of two neuropeptide-degrading activities in membranes of Aplysia tissues. These two enzymes have many properties in common with the mammalian aminopeptidase N and the neutral endopeptidase, respectively.
MATERIALS AND METHODS
Animals
Aplysia californica weighing 75 to 150 g were purchased from Marinus (Long Beach, CA) and maintained in an aerated recirculating see water tank at 15°C for less than 2 weeks before being sacrificed.
Membrane preparations
Tissues from A. californica were dissected out, homogenized at 4°C with a Polytron homogenizer and centrifuged at 95,000 x g for 1 h at 4°C in a Beckman SW 27 rotor through a 41 % (w/v) sucrose cushion. The white interfacial band of plasma membranes was collected and pelleted by centrifugation at 95,000 x g for 30 min at 4°C as described before (BAWAB et al., 1992) .
Analysis of leu-enkephalin and FMRFa metabolites In order to determine the specificity of the enzyme, the labeled cnkcphalin and the nonlabeled FMRFa metabolites (or those of its analogs) were analyzed by reversed-phase high pressure liquid chromatography (RP-HPLC) on a C 18 gbondapak column (Waters). Elution of the metabolites was performed by washing the column successively with the following buffcrs at a flow rate of 1 ml/min: For the enkephalin: from 0 to 30 min, an isocratic step of 100% solvent A (0.15 M Na2HP04-HC'041 pH 2.85, 2.5%
